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a b s t r a c t
We summarized the current knowledge about adaptation processes of isolated immune cells, animal
models and the human body to altered gravity conditions. Many studies indicate an adaptation reaction
of the immune system to the new microgravity environment, at least for the T cell system. Animal and
human studies indicated adaptation processes starting after two weeks and continuing until 6 month
or longer, which was reflected by cytokine concentrations in blood plasma or in stimulation assays.
Adaptive reactions regarding IFN-c, TNF-a and IL-2 concentrations were detected after 12 days space-
flight in animal studies and after 2–4 months in human studies, whereas adaptive reactions regarding
IL-4, IL-6, IL-8 and IL-10 were found after 6 months spaceflight. Cellular studies were performed mainly
as short-term studies, and only a few studies addressed alterations longer than 3 days. However, cross
validation between studies is often not possible or indicated conflicting results. Many in vitro studies,
mostly done with T lymphocytes, demonstrated extensive cellular and molecular alterations. In contrast,
long-term studies with animals and humans are completely lacking this dramatic picture of short-term
cellular effects, which indicates a very efficient adaptation process, partially evidenced by new steady
state of adaptive response in the human immune system after weeks until months. Therefore, we assume
that the human body and its cells are equipped with a robust and efficient adaptation potential when
challenged with low gravitational environments.
 2017 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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1. Introduction
Gravity has been a constant factor throughout the evolution of
life on Earth, and played an important role for the architecture and
morphology of all biological systems. It can therefore be assumed
that abrupt changes of the gravitational force have an impact on
the function of living organisms. It is of great interest, if and how
cellular and molecular functions adapt to gravitational changes
or if they strictly depend on Earth’s gravity. Many studies have
been performed analyzing the effects of altered gravity on life from
unicellular organisms to humans. In humans the current level of
knowledge is that altered gravity, especially microgravity, leads
to numerous deconditioning symptoms like bone demineraliza-
tion, muscle atrophy, reduced performance of the cardiovascular
system, altered neurovestibular perception as well as strong
impairment of the immune system [1–4]. The dysregulation of
the immune system under spaceflight conditions is described by
vast number of reports [5–13]. The first observations were made
already in the 1960s and 1970s where half of the Apollo astronauts
developed bacterial or viral infections during spaceflight or shortly
after returning to Earth [14]. Viral infections include also reactiva-
tion of latent viruses like the varicella zoster virus, cytomegalo-
virus and Epstein-Barr virus [15–19]. Furthermore, investigations
of astronauts during and after their ISS (International Space
Station) missions showed allergic hypersensitivity symptoms
especially for the skin, indicating a loss of regulatory immune sys-
tem function under spaceflight conditions [20,21]. At the cellular
and molecular level post-flight dysregulation of the function of
the human immune system has been reported frequently. Findings
after landing include differences in immune cell subpopulations
like e.g. in the distribution of peripheral blood leucocytes
[22,23,7]. Furthermore, the reactivity of certain cell subsets is
affected. Analyses of blood samples of nine astronauts after return-
ing from the Skylab space station showed a reduced activation
potential of lymphocytes upon mitogenic stimulation in compar-
ison to the pre-flight data [24].
However, comparing the results of the numerous different mis-
sions, variable results were obtained for the different immune cell
subsets [7]. Nevertheless, the collected data point out that cell pop-
ulations are very sensitive to exposure to spaceflight conditions
including launch and landing [7]. Monocytes, representing cells
of the innate immune system, show a reduction in motility and a
rearrangement of the cytoskeleton during spaceflight compared
to 1 g in flight and ground controls [25]. T cells, representing the
adaptive part of the immune system, are altered in their function.
In Space Shuttle crewmembers, early T cell activation was elevated
while in ISS crewmembers it was significant reduced after landing.
In both cases, the ratio of secreted IFN-c:IL-10 was decreased, indi-
cating a Th2 shift in the astronauts’ immune system [26]. The
knowledge about the humoral immunity is sparse. A few studies
described that immunoglobulin plasma levels are unaltered after
short-term spaceflights [27–29]. Contradictory results are reported
for long duration space missions. While one study described
increased serum levels of IgA and IgG [30], another analysis
showed that total serum levels of IgA, IgM and IgG were not signif-
icantly changed during long-term missions [29]. However,
research in the amphibian Pleurodeles waltl showed no changes
in the IgM heavy chain transcription but a threefold increase in
the level of IgY heavy chain transcription, an analog to human
IgG [31,32].
The dysfunction of lymphocytes, resulting in immune deficien-
cies, is thought to represent an enormous risk for long duration
spaceflights [7]. Alterations in the immune response could cause
a dysbalanced response to infections or cancer or lead to hypersen-
sitivity reactions with severe clinical manifestations [33,34,6].
Hence, the underlying mechanisms of these immune dysfunctions
need to be elucidated. Additionally to microgravity, the high psy-
chological stress, as well as the high levels of radiation experienced
in this extreme environment, represent environmental stressors.
Nevertheless, based on numerous publications, there is strong evi-
dence that microgravity is a factor that could be considered as
major reason for an affected immune cell function during space-
flight [35–37]. During the last 40 years more and more studies
came up investigating the influence of altered gravity on immune
cells isolated from animal or human organisms. It could be shown
that inter alia molecular mechanisms and signal transduction cas-
cades are directly affected by microgravity or hypergravity. Hence,
isolated lymphocytes are an ideal model to study direct primary
effects of altered gravity at the cellular level without disturbing
or interfering secondary and systemic influences of the entire
organism. A combined approach of experiments performed on dif-
ferent microgravity platforms complemented with studies using
ground based facilities [38] are important for the investigation of
cellular and molecular processes influenced by altered gravity.
Ground based facilities like clinostat, rotating wall vessel and ran-
dom positioning machine, represent valuable tools since they often
provide microgravity induced comparable results and therefore
offer the possibility for relatively cost effective and fast investiga-
tions. Despite the enormous number of studies, we do not yet have
a complete overview about the functions of the immune system in
altered gravity including adaptation processes and reaching of new
steady state levels [39].
This review provides an overview about the current status of
knowledge of the effects of spaceflight on cells of the immune
system with regard to adaptation in cell culture systems, animal
models and human studies. We aimed to compile existing studies
regarding the measured time points for potential adaptation
effects.
2. Cellular studies
Many studies have been published where immune cells have
been cultivated under spaceflight conditions with or without acti-
vation. The great advantage of cell culture studies is that direct and
primary effects of altered gravity can be investigated on the cellu-
lar level. T cells, representing the adaptive immune system have
been analyzed since long and are most likely the best investigated
immune cells in cell culture.
Experiments that were performed under real as well as under
simulated microgravity conditions showed that non-activated
and activated T lymphocytes react sensitive to gravity with respect
to cell cycle regulation [40], epigenetic [41] and chromatin regula-
tion [42], differential gene expression [40,43] and micro RNA
expression profile [44], cell motility [45,46], and regulation of
apoptosis [47–49]. Furthermore, expression of cytokines such as
interleukin- (IL-) 2, and interferon-gamma (IFN-c) were changed
in microgravity [50].
The effect of microgravity on the cell proliferation, maturation
and function was analyzed in vitro by many groups. However, often
only a single time point was measured and a time course monitor-
ing the progress of the changes is missing – often due to technical
and operational constraints. Table 1 summarizes the influence of
microgravity and simulated microgravity on T cell proliferation
after activation, a requirement for a functional immune response.
The results of the different groups are listed according to the length
of exposure to microgravity. In vitro activation of T cells under real
microgravity was investigated only scarcely and is indeed
described only in a few reports [43,51–53,38,54]. One describes
the experiments from Cogoli and colleagues, which were per-
formed during the Spacelab 1 mission in 1983 [51]. The reactivity
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of the analyzed T lymphocytes upon stimulation with Concavalin A
(ConA) was nearly completely abrogated after 71 h of microgravity
[51,52] and after 72 h respectively [54,38]. Further experiments
showed that the proliferation capacity of T cells in real micrograv-
ity is reduced already after 1.5 h [43]. A larger number of experi-
ments have been performed under simulated microgravity with
exposition times between 0.5 h up to 72 h (Table 1). For all ana-
lyzed time points the investigated T cells showed a clear reduction
in their proliferation activity. This leads to the conclusion that T
cells, at least within a time frame of 72 h, do not adapt to micro-
gravity and are not able to restore the malfunction in cell prolifer-
ation. Interestingly, when ConA CD3/CD28 activated and exposed
to hypergravity for 21 days, T cells reacted in a reversed mode with
an increased proliferation rate [55].
Besides proliferation, T cell signaling has also been intensively
investigated and it could be shown that microgravity influences
the membrane proximal T cell receptor signaling (Table 2).
Investigation of CD3, IL-2R, and LAT expression showed a reduced
protein expression in activated and non-activated T lymphocytes
during the first 6 min under real as well as under simulated micro-
gravity [56,57]. Further studies concerning CD3 protein expression
under simulated microgravity indicated that this decreased
expression is balanced after approximately 30 min [57] (Table 2).
For IL-2R the protein expression returned to normal values in
activated T cells after 71 h exposure to real microgravity. So far
experiments in simulated microgravity have been only performed
up to 12 h [58] and results confirming an adaptation after 71 h
incubation are still missing. For LAT and MAPK signaling results
are rudimentary, and it cannot be concluded if there are adaptation
processes. Furthermore, the influence of hypergravity on the mem-
brane proximal T cell receptor signaling is mostly unknown. Only
two reports exist describing a reduced protein expression in
activated and non-activated T lymphocytes after 20 s and 43 s
[56,57] (Table 2).
Cytokine release has also been intensely investigated in T cells
under real and simulated microgravity. Cytokines function as sig-
naling molecules and are important for inter-cellular communica-
tion and activation of immune cells and immune cell subsets.
They are also important for the regulation of the extent of an
immune response and therefore possess a rather short half-life
and function at low concentrations. Table 3 shows the cytokine
release of T lymphocytes under real and simulated microgravity
at different time intervals. While IFN-c, and TNF-a release was
increased under real microgravity for all measured time points,
studies under simulated microgravity showed the reverse effect
and cytokine down regulation was observed in the experiments
lasting between 24 h and 144 h. For IL-2 the largest number of
data points were published. In real microgravity, down regulation
of cytokine release (46 h) was followed by an increased secretion
after 71 h and 72 h in microgravity, indicating either a compen-
satory effect or homeostasis at a new ‘‘steady state” level. IL-2
decrease but not increase after 71 h could be confirmed in simu-
lated microgravity experiments (Table 3). Analyses for IL-1, IL-1b
and IL-6 showed increased release values in simulated micro-
gravity when T cells were stimulated via ConA CD3/CD28. How-
ever, under real microgravity, contradictory results were obtained
after 24 h exposure when cells were stimulated with PMA or LPS.
This result indicates that microgravity may affect the cellular tar-
get of phorbol ester [59]. Regarding PMA, this could be an indica-
tion that PMA may not work under microgravity conditions. It is
also conceivable that activation of the PMA receptor, protein
kinase C, was inhibited, either because PMA did not bind or
because protein kinase C activation was blocked in microgravity.
More studies about the activation of T cells under PMA are
needed but still, there is an indication that intracellular signaling
pathways are sensitive to gravity [59]. Licato et al. studied the
influence of IL-2 activation and observed a down regulation of
IFN-c, TNF-a, and IL-1b after 48 h and 144 h. As the induction
by IL-2 of secondary cytokines like IFN-c, IL-1b, and TNF-a is
an important aspect of IL-2 activation of immune functions, this
abrogation suggests that IL-2 signaling pathways leading to vari-
ous IL-2-mediated effects are differentially regulated under the
tested conditions. A possible explanation could be the inhibition
of CD25 (IL-2R alpha chain) upregulation in IL-2-stimulated
cultures [60].
Table 2
Changes in protein expression after different time intervals in activated and non-activated T cells.
T cells exposed to microgravity and
simulated microgravity
CD3 IL-R2 MAPK LAT
non activated ; 20 s [57] ; 20 s [57] ; 6 min [56] ; 20 s [57]
; 6 min [56] ; 6 min [56]
ConA CD3/CD28 (activated) ; 5 min, 15 min [57] ; 6 min [56] ; 30 min " 20 s (MEK phosphorylation) –
; 6 min [56] 60 min [57] [117]
M 30 min, 60 min [57] " 5 min [57]
PMA (activated) – – " 20 s (MEK –
phosphorylation) [117]
" 5 min [57]
1–12 h microgravity
ConA CD3/CD28 (activated) – ;4, 6, 8, 10, 12 h [58] – –
>12 h microgravity
ConA CD3/CD28 (activated) – M71 h [118] – –
T cells exposed to hypergravity
non activated ; 20 s [57] ; 20 s [57] – ; 20 s [57]
ConA CD3/CD28 (activated) ; (5-7 g, 43 s) [56] ; (5-7 g, 43 s) [56] ; (5-7 g, 43 s) [56] ; (5-7 g, 43 s) [56]
" increase, ; decrease, M no changes, (–) not analyzed, underlined arrows correspond to simulated microgravity experiments.
Table 1
T cell proliferation after stimulation under real and simulated microgravity
conditions.
T cell proliferation Real microgravity Simulated
microgravity
ConA CD3/CD28 (activated) ; 1.5 h [43] ; 0.5 h [110]
; 3, 24, 48 h [111]
; 71 h [51], [52], [53] ; 24, 48, 72 h [112]
;72 h [38] ; 24, 48 h [113]
;72 h [54] ; 24, 48, 72 h [114]
;72 h [38]
PMA (activated) – ; 48 h [115]
CD3/IL-2 (activated) – ; 24 h [116]
(") increase, (;) decrease, (M) no changes, (–) not analyzed, underlined arrows
correspond to simulated microgravity experiments.
24 C.S. Thiel et al. / REACH - Reviews in Human Space Exploration 5 (2017) 22–32
Taken together, we see that there are numerous gaps in the
investigation of the influence of real and simulated microgravity
on the cytokine release of activated T cells with respect to the time
course from short-term to long-term microgravity. In the case of
ConA CD3/CD28 T cell stimulation and IL-2 release, where the most
data are present, indications for adaptation processes are visible
after approximately 3 days. Research in this field should be inten-
sified, especially using the cost effective ground based simulated
microgravity facilities to investigate in more detail if and when
adaptation processes appear.
Studies published about other immune cell types include natu-
ral killer (NK) cells, which remained unaltered in their function in
cell culture [61] as well as monocytes and macrophages. The cell
line J-111 was functionally impaired during spaceflight and a
distinct reduction in the cellular motility could be observed
compared to 1 g in-flight and ground controls [25]. In macrophages
a rapid and reversible response to altered gravity was observed
[62,63]. Macrophages belong to the monocyte-macrophage-
system (MMS) of the body’s innate immune system and represent
the first line of defense against microbial infections. The effective-
ness of reactive oxygen species (ROS) production upon stimulation
was investigated in a combined approach using 2D clinorotation
and real microgravity on parabolic flights. The macrophageal
oxidative burst, which is decreased upon microgravity and
increased by hypergravity [62], is one of the key elements of the
innate immune response and cellular signaling [64]. However,
long-term functional analyses in real microgravity are still missing
for this type of immune cells.
Cell culture experiments represent most likely the best and
most cost effective option to generate a reliable in vitro basis of
data for analyses of cells of the immune system exposed to real
and simulated microgravity. Especially ground-based facilities like
clinostats represent an excellent way to perform continuous exper-
iment timelines from minutes to hours and days to investigate the
effect of altered gravity on cells of the immune system and to
discover adaptation effects and new levels of homeostasis.
Surprisingly, in vitro studies are rare and were performed mainly
as short-term studies with data points until 3 days, indicating that
the experimental potential of in vitro studies is not exhausted by
far, in particular with regard to ground-based clinostat studies.
3. Animal models
Animals, especially mice and rats represent widely used model
organisms to elucidate biological phenomena and mechanisms and
to better understand disease processes. Research in rats and mice
have been deployed in rather short-term experiments of up to
approximately two weeks microgravity because of lack of technical
facilities for long duration flights. With respect to the proliferation
rate of T lymphocytes, no significant changes after 8 days in rats
[65] and 15 days in mice [66] could be observed. In experiments
that have been performed to determine the effects on the cytokine
production, cells were isolated from flown animals shortly after
landing and stimulated with mitogens to induce cytokine secre-
tion. The results in Table 4 display that the production of different
cytokines is not uniformly affected by spaceflight. The immune-
regulatory and antiviral cytokine IFN-c is initially increased after
one to two days in microgravity. Thereafter, from day 12 onwards
the cytokine release is decreased, indicating an adaptation to the
new environment. In contrast, after 21 days in hypergravity, the
IFN-c secretion is significantly increased (see Table 4). TNF-a
release was also elevated in mice after one and two days in micro-
gravity. After 12 days in microgravity, TNF-a secretion returned to
a normal level when compared with ground control animals and
IL-2 was down regulated. However, the careful interpretation of
data is required, because the early data points were recorded for
mice and the later data points for rats. For IL-1, IL-4, IL-5, IL-6,
IL-10, IL-17A, no prediction of an adaptation or a persisting dysbal-
ance is possible because of lacking data points.
4. Astronaut studies
Several reports describe severe effects of spaceflight on
the astronauts’ immune system comparing between pre- and
Table 4
Changes in cytokine release after different time intervals in activated T cells of animal models.
Microgravity IFN-c IL-4 IL-5 IL-10 IL-2 IL-17A TNF-a IL-6 IL-1
ConA CD3/CD28
(activated)
d" 1d,2d [119] d;12d [120] dM 12d [120] – ▲M 8d [66] – d" 1d,2d [119] – d" 1d,2d [119]
d;12d [120] ▲M 10d [28] dM 12d [120]
d; 15d [121] d; 12d [120]
d; 15d [121]
PMA (activated) – – – – ▲;10d [28] – – – –
LPS (activated) – – – d;13d [122] – – dM 13d [122] d;13d [122] –
Hypergravity d "" 21d [55] dM 21d [55] dM 21d [55] dM 21d [55] d;;21d [55] – – – –
dMouse ▲Rat, " increased "" strongly increased, ; decreased ;; strongly decreased M no change.
Table 3
Changes in cytokine release after different time intervals in activated and non-activated T cells.
Microgravity and simulated
microgravity
IFN-c IL-2 TNF-a IL-6 IL-1b IL-1
ConA CD3/CD28 (activated) "" 71 h [118] ;2, 4, 6, 8, 10, 12 h [58] – ""24, 48, 72 h [112] ""24, 48, 72 h [112] " 4, 6, 8, 10, 12 h [58]
"" 72 h [54] ;46 h [58]
;24, 48, "" 71 h [118]
72 h [112] " 72 h [54]
;24, 48, 72 h [112]
PMA (activated) – ; 24 h [59] – – – ;24 h [59]
; 48 h [115]
LPS (activated) " 24 h [119] – " 24 h [119] – – " 24 h [119]
IL-2 (activated) ; 48, 144 h [60] – ;48, 144 h [60] – ;48, 144 h [60] –
" increase, ; decrease, M no changes, () not analyzed, underlined arrows correspond to simulated microgravity experiments.
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post-flight data, directly before launch and after landing, where
dysfunctions regarding cell proliferation as well as for cell func-
tions like cytokine release have been observed [22,26,8,30]. How-
ever, due to the diverse stress factors that affect astronauts
directly before and during launch and landing, as well as during
the spaceflight [17,19,36], other factors in addition to the gravita-
tional changes might have a significant influence on the organism
and might superimpose the direct effects of microgravity. Recently,
new investigations, including baseline data recordings before and
after spaceflight as well as in flight sampling at different time
points, provided new insights into the function of the human
immune system during spaceflight.
The following tables display the results of three different stud-
ies concerning the changes in cytokine levels. Table 5 summarize
the cytokine concentration in the blood plasma of astronauts
before, during and after a short duration spaceflight of 10 to
15 days [9]. Samples were taken 180 days before launch (L-180),
at L-10, during the flight (FLT; i.e. the day before landing) and
directly after landing (R + 0) and 14 days post-flight. Data are dis-
played as differences in cytokine levels. Two consecutive data
points were compared with each other and the cytokine up- or
down-regulation was displayed with arrows. For all measured
cytokines, an increase after 10 to 15 days spaceflight could be
detected including IL-1b and IFN-a, which were considerably
increased upon exposure to microgravity. Blood plasma levels of
all cytokines decreased immediately after landing, except for IL-
6, which decreased only 14 days post-flight. 14 days after landing,
the last measured time point, the plasma levels of IL-1b, IL-4, IL-6,
IL-10, IL-12 and IL-17 returned to their pre-flight level. TNF-a, IFN-
a and IFN-c showed higher plasma concentrations 14 days after
landing compared to L-180. The concentration of IL-6 was signifi-
cantly increased directly after landing while the plasma levels of
all other measured cytokines were significantly increased during
spaceflight. Measurements of in-flight cytokine profiles (IFN-a,
IFN-c, IL-1b, IL-4, IL-10, IL-12 and TNF-a) could clearly separate
in-flight dysregulation from stress induced alterations immedi-
ately after landing (Table 5). Table 6 summarizes the mean intra-
cellular and secreted cytokine concentrations in stimulation
assays: To monitor intracellular cytokines, PMA/ionomycin was
used as stimulant for 4 h. For the detection of secreted cytokines,
cells were stimulated for 48 h with either anti-CD3/CD28 (T cell
specific stimulation), LPS or PMA/ionomycin. IFN-c, IL-10 and IL-
17A were significantly reduced in-flight while IL-2 levels were sig-
nificantly elevated. TNF-a after anti-CD3/CD28 or LPS stimulation
was significantly elevated while TNF-a after PMA/ionomycin stim-
ulation was decreased in-flight. After PMA/ionomycin stimulation,
IL-4, IL-5 and IL-6 were significantly decreased in-flight. Following
LPS stimulation, IL-8, IL-1b, and IL-6 were increased during flight,
whereas IL-12 and IL-4 production was unaltered after anti-CD3/
CD28 stimulation. Most of the cytokines that were dysregulated
during flight remained also dysregulated after landing, whereas
for IFN-c and IL-6 a tendency towards baseline was observed.
Further investigations with 28 ISS astronaut crewmembers
included additional measurement points before and during flight.
Cytokine blood plasma levels were measured at L-180, L-45,
L-10, flight day 15 (FLTd15), FLTd30, FLTd60, FLTd120, FLTd180,
R + 0, and R + 30 [67]. IL-1a, IL-6, IFN-c, IL-2, IL-17, IL-4, IL-5,
IL-10, and GM-CSF concentrations were below or only marginally
above the sensitivity threshold, therefore no evaluation of cytokine
changes were possible. Fig. 1 summarizes the mean plasma
Table 5
Differences in blood plasma cytokine concentrations in astronauts during spaceflight
(data adapted from [9]).
Cytokines L-10 vs. L-180 FLT vs. L-10 R + 0 vs. FLT R + 14 vs. R + 0
IL-1b " """ ;; ;
TNF-a " " ; "
IL-6 " " " ;
IL-12 " " ; "
IFN-a " "" ; "
IFN-c " "" ; "
IL-4 " " ; M
IL-10 " " ; ;
IL-17 " " ; ;
" increase ; decrease M no change, " weak "" moderate """ strong.
Table 6
Intracellular and secreted cytokine concentrations in stimulation assays, blood sample from astronauts after different time points in altered gravity
conditions (data adapted from [9]).
Cytokines L-10 vs. L-180 FLT vs L-10 R + 0 vs. FLT R + 14 vs. R + 0
CD4/IL-2 (PMA/ionomycin) ; M ; "
CD8/IFN-c (PMA/ionomycin) " ; ; "
IFN-c (anti-CD3/CD28) " ;;; " ""
IFN-c (PMA/ionomycin) ; ; ; ""
TNF-a (anti-CD3/CD28) " "" ;;; "
TNF-a (PMA/ionomycin) ; ;; " """
TNF-a (LPS) " """ ;; ;
IL-10 (anti-CD3/CD28) ; ;;; """ ;
IL-10 (PMA/ionomycin) ; ;;; """ """
IL-10 (LPS) M ;;; "" ;;
IL-4 (anti-CD3/CD28) M M M M
IL-4 (PMA/ionomycin) M ;;; M """
IL-5 (anti-CD3/CD28) " ; M """
IL-5 (PMA/ionomycin) ; ;; M """
IL-2 (anti-CD3/CD28) "" "" ;;; """
IL-2 (PMA/ionomycin) ; " ; "
IL-17A (anti-CD3/CD28) ;;; ;;; """ ""
IL-17A (PMA/ionomycin) "" ;;; """ """
IL-6 (anti-CD3/CD28) " " ; ;
IL-6 (PMA/ionomycin) "" ;;; "" ""
IL-6 (LPS) ; " M ;
IL-12 (LPS) M M M M
IL-1b (LPS) ; """ ; M
IL-8 (LPS) " " " ;
" increase ; decrease M no change " weak "" moderate """ strong.
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cytokine concentrations (pg/ml) in astronauts before, during, and
after spaceflight from Table 2 from [69]. The published tabular val-
ues for the mean plasma cytokine concentrations were plotted and
displayed in diagrams. Values within the same order of magnitude
were combined in a common graph (Fig. 1a–e). Fig. 1 shows that
cytokines were mostly increased after 15 days of spaceflight
(TNF-a, IL-8, IL-1ra, CCL5/RANTES, CXCL5/ENA-78, CCL4/MIP-1b,
VEGF, Tpo). However, only IL-8, Tpo and CXCL5/ENA-78 were sig-
nificantly elevated during nearly all time points during spaceflight,
whereas IL-1ra, VEGF and CCL4/MIP-1b demonstrated at least one
significant increase during flight. TNF-a was not significantly
altered. IL-8 and CXCL5/ENA-78 remained elevated until flight
day 180, indicating a new steady state level, whereas, Tpo secre-
tion increased constantly until FLTd180 without reaching a steady
state in the measured time interval. In contrast, G-CSF,
Granulocyte-Colony Stimulating Factor, was first decreased until
FLTd30, when compared to the baseline level (L-180), then
increased until FLTd120, and thereafter reduced at FLTd180 and
returned to baseline at R + 30. FGFb, basic fibroblast growth factor,
concentration decreased at FLTd15, followed by a twofold increase
until FLTd60, before it returned to baseline levels between FLTd120
and FLTd180. However, alterations of FGFb and G-CSF were not sig-
nificant in statistical tests. CCL3/MIP-1a, macrophage inflamma-
tory protein 1-alpha, was first slightly increased compared to the
baseline level (L-180), then reduced at FLTd30 and returned to
baseline level at FLTd180, however also with non-significant val-
ues. Overall, single data points of individual astronauts demon-
strated a strong variability in cytokine concentrations during
spaceflight conditions.
Crucian and colleagues published another very valuable study
investigating the effect of long duration spaceflight on the cytokine
release of mitogen stimulated PBMCs [10]. Blood samples were col-
lected at L-180, L-45, FLTd14 (early), FLT 2 to 4 months (mid-
mission), FLT 6 months (late), R + 0, and R + 30 (Table 7). PBMCs
were stimulated in culture under the presence of either
anti-CD3/CD8 to activate T cells via their T cell receptor, PMA/ion-
omycin representing a broader pharmacological stimulus, and
lipopolysaccharide (LPS) for monocyte activation. Table 7 summa-
rizes the results of the cytokine release from stimulated PBMCs.
Concentrations of IFN-c, IL-4, IL-5, IL-10, IL-17A, TNF-a, and IL-6
were all significantly decreased at all three in-flight time points
[10]. Following stimulation with LPS, no significant decreases were
observed during flight, but the concentration of IL-8 was actually
increased at all three in-flight time points [10]. It could be hypoth-
esized that short-term microgravity tends to inhibit human T cell
function during the first days and weeks. This is also in line with
data obtained from cell culture and animal models. Then, after
two until four months under microgravity conditions, an
adaptation process seemed to start in T cells, where the lowest
point in cytokine release was detected for most of the measured
Fig. 1. Plasma cytokine concentrations during long duration spaceflight. Data are adopted from [69] and the published tabular values were plotted in diagrams (a–e). The
mean plasma cytokine concentrations were expressed as mean concentrations (pg/ml) of the respective cytokine in 28 astronauts. Values that were constantly below or only
marginally above the indicated sensitivity threshold were not included in the diagrams. When cytokine concentrations were below the detection limit, the sensitivity
threshold was displayed (valid for IL-1b: L-180, L-45, L-10, FLTd15, FLTd30; TNFa: L-180, L-45, L-10; IL-8: L-180, L-45). a) IL-1b showed only minor in-flight alterations, while
TNFa and IL-8 were clearly increased from FLTd15 on. b) For IL-1ra no major changes could be observed except a slight trend of increased expression, which was visible from
L-10 onwards. For CCL5/RANTES the measured data points were rather fluctuating and no obvious trend was detectable throughout the measurement. Blood plasma
concentrations for CXCL5/ENA-78 increased clearly already at FLTd15 and stayed increased until return to Earth (R + 0). c) VEGF and CCL4/MIP-1b levels increased both in-
flight from FLTd15 onwards. d) Tpo concentrations in blood plasma showed slowly but steadily increasing values, while CCL2/MCP1 was rather stable in-flight but increased
at R + 0. e) G-CSF, FGFb and CCL3/MIP-1a showed a rather fluctuating data situation as they respond with an over- and undershooting reaction respectively before they
showed the tendency to return to the baseline values during flight.
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parameters. In case of IL-4 (anti-CD3/CD28), and IL-6 (anti-CD3/
CD28), a possible turning point is visible only after 6 months in
microgravity (late). The measurements for IL-2 (anti- CD3/CD28)
and TNF-a (anti-CD3/CD28) secretion showed rather fluctuating
results, making an evaluation of potential adaptation processes dif-
ficult. The stimulation of monocytes by LPS also showed rather
heterogenic results: The concentrations for IL-1b and IL-6 are fluc-
tuating, whereas TNF-a secretion was constantly decreased until R
+ 0. For IL-8 and IL-10, an inversion of the cytokine release and
therefore a possible trend for an adaptation process was visible
only in the late phase of microgravity exposure after 6 months.
5. Countermeasures
Long duration spaceflights to another planet as planned by
NASA and other space agencies represent a risk for the health sta-
tus of the astronauts. The immune system is challenged during
space travel by various factors such as isolation or confinement
[68], psychological stress, altered nutrition, altered microbial viru-
lence [69,70,71,72], altered microbiomes [73], increased biofilm
formation [74], circadian misalignment, radiation, and micrograv-
ity [75]. The effects are manifold and affect the innate as well as
the adaptive immune system [76,26,7,15].
Nowadays countermeasures applied to reduce the risk for astro-
nauts to develop infectious diseases are resumed in the so-called
Health Stabilization Program (HSP). Astronauts are isolated pre-
flight and subjected to quarantine 7 days before launch (L-7) where
they have only limited contact to other individuals to reduce the
infection risk. The HSP also includes surveillance of the astronauts’
health status by blood and urine sample analyses of the crewmem-
bers [75,77]. Additionally, the medical and dental history is ana-
lyzed as well as the vaccination status for influenza, tetanus,
diphtheria, pertussis, mumps, measles, and rubella. Furthermore,
the astronauts are screened for tuberculosis, S. aureus and HIV
infections [77]. Not only the crewmembers are intensely screened
but also the spacecraft and the space station, which could be con-
taminated by microorganisms [78]. Microbes have been identified
in free-floating condensates aboard the Mir space station [79].
Therefore, aerosols produced by coughing or speaking represent a
danger for transmission of viruses like influenza [80] and bacteria
such as S. aureus [81] from one crewmember to another. Counter-
measures are also applied considering the equipment of the space
vehicle and the space station. The air is filtered by a high-efficiency
particular air (HEPA) filter and the air humidity is controlled [77].
Water filters that are utilized and improved contamination resis-
tant surfaces should be implemented [82]. Besides these hygienic
and environmental controls, astronauts are obliged to do regular
exercise, which could be also beneficial for the function of the
immune system during space travel [83].
However, this is not sufficient to cope with the above-
mentioned spaceflight effects that are likely to be associated with
decreased resistance to viral and bacterial infections as well as an
increase in allergic and autoimmune complications [84]. Further
prophylaxis treatment was proposed regarding nutritional mea-
sures like the intake of substances, which have several positive
effects such as modulation of the innate and adaptive immunity
[85,86], benefits on the response to vaccination for influenza
[87], polio [88] and cholera [89]. Additionally, it could be shown
that some plant derived medicines and herbal products caused
immune modulatory responses like e.g. Saikosaponin from Buple-
tum falcatumwhich increased the IL-2 production [90] and Silybum
marianum derived from the milk thistle, which acts immunostim-
ulatory [91]. Furthermore, application of nutritional supplements
showed promising results: In particular, molecules with anti-
oxidant properties are promising countermeasures against
oxidative stress that is associated with spaceflight and radiation
exposure [92–94]. An anti-oxidative and protective function
against space radiation induced oxidative stress could be
shown for N-acetyl cysteine, ascorbic acid, a lipoic acid, L-
selenomethionine, coenzyme Q10 and vitamin E succinate
[95,96]. Kennedy and colleagues could also show that administra-
tion of D-selenomethionine reduced the irradiation induced
decrease of total antioxidants [97]. Tocopherol, has been shown
to be effective in correcting altered IL-6 production and in decreas-
ing synthesis of acute phase proteins [98], [99]. Vitamin D supple-
mentation led to an enhanced immune function [100] and reduced
the risk of herpes virus reactivation [101].
The effects of nutritional nucleotide supplementation on the
immune function was investigated by Kulkarni and colleagues
[102,103]: Mice were exposed to simulated microgravity effects
Table 7
Cytokine release from PBMCs isolated from astronauts after mitogen stimulation (data adopted from [10]). The published data were resumed by comparing two consecutive data
points [10] and the increase or decrease of cytokine secretion was displayed with up or downward directed arrows. Early = FLT 14 days, Mid = FLT 2–4 months, Late = FLT
6 months.
Cytokines L-45 vs. L-180 Early vs. L-45 Mid vs. Early Late vs. Mid R + 0 vs. Late R + 30 vs. R + 0
IFN-c (anti CD3/CD28) "" ;;; "" "" "" ""
IFN-c (PMA/ionomycin) ; ;;; "" "" "" ""
IL-4 (anti CD3/CD28) " ;; ;; " "" ""
IL-4 (PMA/ionomycin) " ;;; " " "" """
IL-5 (anti CD3/CD28) ; ;; " " "" "
IL-5 (PMA/ionomycin) ; ;;; " "" "" ""
IL-10 (anti CD3/CD28) " ;;; " " """ ""
IL-10 (PMA/ionomycin) ;; ;;; " " "" ""
IL-2 (anti CD3/CD28) "" ;; "" "" ;;; ""
IL-2 (PMA/ionomycin) ; ;;; "" "" "" "
IL-17a (anti CD3/CD28) ;; ;;; " " "" ""
IL-17a (PMA/ionomycin) ;; ;;; " " " """
TNF-a (anti CD3/CD28) " ;; "" ; ; """
TNF-a (PMA/ionomycin) ;; ;;; " " "" ""
IL-6 (anti CD3/CD28) "" ;; ;; " "" M
IL-6 (PMA/ionomycin) ; ;;; " " "" "
TNF-a (LPS) M ; ;; ;; " ""
IL-6 (LPS) ; ;; "" ;; "" ""
IL-1b (LPS) ;; ;;; "" ;; "" "
IL-8 (LPS) " "" " ;; ;; ""
IL-10 (LPS) "" ;;; ; "" "" ""
" increase ; decrease M no change, " weak "" moderate """ strong.
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by hindlimb unloading, which resulted in significant suppression
of immune function and decreased IL-2 and IFN-c concentrations.
These effects were restored when food was supplemented with
RNA or uracil for a time span of 7 days. The administration of the
supplemented chow could restore various immunological func-
tions [103,104], such as cell proliferation and cytokine production
[105,106,104], reduced corticosteroid levels [103], regulated T cell
growth and – function [103,104], increased cell locomotion [103],
decreased melanoma metastasis and improved wound healing
[104]. This leads to the conclusion that in stress situations such
as spaceflight, substitute food has highly regulating and immuno-
protective effects and could therefore represent an important
countermeasure for immune dysfunction in space [103].
Another interesting substance is active hexose correlated com-
pound (AHCC), an alpha-glucan, produced by the mycelia of Basid-
iomycete mushrooms. This compound enhanced the resistance of
hindlimb unloaded mice to Klebsiella pneunomiae infection [107]
as well as the TH1 response in ConA activated splenocytes [108].
Administration of non-purified leukocytic and fibroblast inter-
feron, restored the NK cell activity in mice after exposure to a
stressor [109].
Successful results have also been achieved with the therapeutic
use of biological response modifiers (BRM). The following
approaches showed promising results in the treatment of cancer
(CSF and IFN-c, recombinant mutant TNF-S), infectious diseases
(TNF against Hepatitis B) and autoimmune reactions (CSF against
autoimmune neutropenia) [68].
Applications included:
 induction of cell maturation and differentiation (erythropoietin,
thymus hormones, colony-stimulating factors CSFs)
 cytokines and recombinant mutants (interleukins IL-2 and IL-4),
interferons, TNF-a
 natural and synthetic immunomodulators (LPS, Muramyldipep-
tide MDP, lectins)
 cells like natural killer (NK) cells, lymphokine-activated killer
(LAK) cells, tumor-infiltrating lymphocytes (TILs), cytotoxic T
lymphocytes (CTLs)
 cytostatic agents
A very effective approach of modern immunotherapy is also the
application of artificial vaccines, monoclonal antibodies and
immunoconjugates, recombinant cytokines, or immunomodula-
tors, mostly applied in transplantation and cancer medicine [68].
The currently most common treatment in astronauts during an
infection is the administration of antibiotics. However, bacteria in
microgravity showed an enhanced resistance to antibiotics. There-
fore the above-mentioned substances and methods have to be fur-
ther evaluated and new combinations and strategies have to be
analyzed to handle this problem. It will be important to find
suitable compilations of substances and methods to mitigate the
negative effects of spaceflight on the human body and to enable
astronauts to perform long duration spaceflight as required for a
mission to another planet.
6. Conclusion
Taken together these studies indicate an adaptation reaction of
the immune system to the new microgravity environment, at least
for the T cell system. Animal and human studies indicated adapta-
tion processes starting after two weeks and continuing until
6 months or longer, which was reflected by cytokine concentra-
tions in blood plasma or in stimulation assays. Adaptive reactions
regarding IFN-c, TNF-a and IL-2 concentrations were detected after
12 days of spaceflight in animal studies and after 2–4 months in
human studies, whereas adaptive reactions regarding IL-4, IL-6,
IL-8 and IL-10 were found after 6 months spaceflight. Interestingly,
IL-8 and CXCL5/ENA-78 remained significantly elevated during the
entire spaceflight, both cytokines are important regulators of neu-
trophil recruitment. Importantly, cellular studies were performed
mainly as short-term studies, and only a few studies addressed
alterations longer than 3 days. Long-term in vitro studies are com-
pletely missing. Therefore, more detailed and prolonged data anal-
ysis with narrow-meshed data points are necessary to identify and
understand adaptation mechanisms of the immune system in
altered gravity. The current knowledge is mainly based on single
data point analysis in studies with a great variability in design,
and lack of systematic reciprocal validation across the different
model systems. Of course, this situation may be caused at least
partially by the operational, technical and administrative con-
straints of spaceflight experiments.
Although many dysfunctions of the immune system have been
described in astronauts during short duration spaceflight, the
amount of medical incidences is limited and the immune problems
are rather minor during short and long duration flights. So far no
live threatening event has been reported during the last decades
associated with a malfunction of the immune system. Observed
symptoms include: allergic reactions, prolonged congestion, rhini-
tis, sneezing, cold sore, ear related pain, congestion and itchiness,
pharyngitis, skin infection, skin rash and hypersensitivities, urinary
tract infections and other infections (Table 8). This observation
leads to the assumption that adaptive responses of cells and whole
organisms could be expected under microgravity and altered grav-
ity in general.
We summarized the current knowledge about adaptation pro-
cesses of isolated immune cells, animal models and the human
body to altered gravity conditions. Cross validation between
in vitro and in vivo studies is often not possible or indicated con-
flicting results. For example, T cell proliferation was decreased
in vitro and without indications of adaptions, confirmed in many
studies, whereas no significant decrease in T cell proliferation
was detected in vivo in rat and mice after 8 and 15 days of space-
flight, respectively. Blood cell counts in astronauts showed only
minor changes in general lymphocyte and T cell counts [10]. Con-
cerning different T cell subsets, a heterogeneous situation was
observed. However, an overall down regulation trend was visible
when compared to baseline values (L-180) [10]. T cell proliferation
studies from astronauts that experienced long duration flights are
mostly lacking. T cell signaling was mostly studied in cell culture
systems in real and simulated microgravity in short time frames
until 3 days. Up to now, we have no knowledge about molecular
alterations of T cell signaling or adaptation responses in the signal
transduction pathways when exposed to long-term microgravity.
In most of the published studies, cytokine concentration in human
blood plasma and in cell culture supernatants from T cells isolated
from animal models or from astronauts were analyzed. Neverthe-
less, the results are fragmentary and further research is required
Table 8
In-flight clinical symptoms, ISS Program through 38 Expeditions; 46 ISS crew




Prolonged congestion, rhinitis, sneezing 20
Herpes virus (cold sore) 6
Ear related: pain, congestion, itchiness 6
Pharyngitis (sore throat) 1
Skin infection 6
Skin rash/hypersensitivity 23
Urinary tract infection 2
Infections and others 4
Total 70
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to fill the existing gaps, in particular coordinated approaches and
standardized protocols could support cross-validation of the pace
and extent of adaption response in the human immune system, fol-
lowing in vitro and in vivo approaches. Such knowledge is of crucial
importance for risk assessment, systematic and validated medical
monitoring and potential countermeasures during exploration
class missions.
Because gravity has been constant throughout the history of
Earth and evolution of life [123], no pre-set adaptation program
can be expected and the cellular response may therefore be less
organized than other adaptation processes. Indeed, a plethora of
in vitro studies, mostly done with T lymphocytes, demonstrated
extensive alterations in almost every cellular and molecular aspect
which were examined in more detail [40–57]. In contrast, long-
term studies with animals and humans are completely lacking this
dramatic picture of short-term cellular effects, which indicates a
very efficient adaptation process, partially evidenced by new
steady state of adaptive response in the human immune system
after weeks until months [69]. Therefore, we assume that the
human body and its cells are equipped with a robust and efficient
adaptation potential when challenged with low gravitational
environments.
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